Register for our free email digests:
Latest From PhotoMedex Inc.
The UK's independent ad regulator suggests the popular no!no! PRO device's clinically demonstrated efficacy may be limited to hair removal at the time of treatment rather than longer-term benefits, making its utility roughly on par with shaving and other traditional methods.
Derived from Strategic Transactions, Informa’s premium source for tracking life sciences deal activity, the Medical Device Deals Update column is a survey of recent medtech M&A, alliance, and financing activity. This month’s column covers deals announced June-July 2015.
Derived from Strategic Transactions, Informa’s premium source for tracking life sciences deal activity, the Dealmaking column is a survey of recent health care transactions listed by relevant industry segment – In Vitro Diagnostics, Medical Devices, and Pharmaceuticals – and then categorized by type – Acquisition, Alliance, or Financing. This month’s column covers deals announced in June 2015.
Device financing rose slightly to $934 million in Q1, while acquisition value was down to just over $4 billion. Diagnostics fundraising dropped significantly to $597 million; M&A activity was dominated by NGS and Roche's transaction with Foundation Medicine.
- OTC, Consumer
- Therapeutic Areas
- Laser Photonics
- Laser Photonics Inc.
- North America
- Parent & Subsidiaries
- PhotoMedex Inc.
- Senior Management
- Dolev Rafaeli, PhD, CEO
- Contact Info
Phone: (215) 619-3600
100 Lakeside Dr.
Horsham, PA 19044
You must sign in to use this functionality
All set! This article has been sent to firstname.lastname@example.org.
All fields are required. For multiple recipients, separate email addresses with a semicolon.